ICON Shares Outstanding 2010-2024 | ICLR

ICON shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • ICON shares outstanding for the quarter ending September 30, 2024 were 0.083B, a 0.57% increase year-over-year.
  • ICON 2023 shares outstanding were 0.083B, a 0.3% increase from 2022.
  • ICON 2022 shares outstanding were 0.082B, a 21.16% increase from 2021.
  • ICON 2021 shares outstanding were 0.068B, a 27.75% increase from 2020.
ICON Annual Shares Outstanding
(Millions of Shares)
2023 83
2022 82
2021 68
2020 53
2019 54
2018 55
2017 55
2016 56
2015 60
2014 63
2013 62
2012 60
2011 61
2010 61
2009 60
ICON Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 83
2024-06-30 83
2024-03-31 83
2023-12-31 83
2023-09-30 83
2023-06-30 83
2023-03-31 83
2022-12-31 82
2022-09-30 82
2022-06-30 82
2022-03-31 83
2021-12-31 68
2021-09-30 81
2021-06-30 53
2021-03-31 53
2020-12-31 53
2020-09-30 53
2020-06-30 53
2020-03-31 54
2019-12-31 54
2019-09-30 55
2019-06-30 54
2019-03-31 54
2018-12-31 55
2018-09-30 55
2018-06-30 55
2018-03-31 55
2017-12-31 55
2017-09-30 55
2017-06-30 55
2017-03-31 55
2016-12-31 56
2016-09-30 57
2016-06-30 57
2016-03-31 56
2015-12-31 60
2015-09-30 60
2015-06-30 62
2015-03-31 62
2014-12-31 62
2014-09-30 63
2014-06-30 63
2014-03-31 63
2013-12-31 63
2013-09-30 62
2013-06-30 62
2013-03-31 61
2012-12-31 61
2012-09-30 60
2012-06-30 61
2012-03-31 61
2011-12-31 61
2011-09-30 61
2011-06-30 61
2011-03-31 61
2010-12-31 61
2010-09-30 61
2010-06-30 61
2010-03-31 60
2009-12-31 60
2009-09-30 60
2009-06-30 60
2009-03-31 60
Sector Industry Market Cap Revenue
Medical Medical Services $16.136B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00